chartexchange

CON vs. MEDP: Which Stock Is the Better Value Option?

Zacks Investment Research | Sep 11, 2026 11:40 AM EDT

A comparison of two Medical Services sector stocks reveals that Concentra Group (CON) is more attractive to value investors than Medpace (MEDP). CON has a stronger Zacks Rank (#1 vs #2), lower valuation multiples (forward P/E of 20.95 vs 33.25, PEG ratio of 1.26 vs 2.60, and P/B ratio of 9.04 vs 37.52), and a better Value grade (B vs D), making it the superior option for value-focused investors.

Read original article